Pharma Likelihood Of Approval
We are the trusted, gold standard intelligence provider to the world’s largest industries
GlobalData powers faster, more informed decisions with:
- Granular industry intelligence: We develop deep, vertical-specific intelligence tailored to your industry, providing 360° insight.​
- Exhaustive coverage: We synthesize our vast data universe into formats that support your decision-making needs, covering the sectors, themes, companies and geographies that matter to you. ​
- Proprietary datasets: We provide you with access to untapped pools of intelligence generated from our proprietary datasets and primary research capabilities. ​
- Robust methodologies: The quality and timeliness of our data is a key differentiator. We leverage robust research methodologies to turn millions of data points into trusted intelligence.
Thousands of companies, government organizations, and decision makers rely on GlobalData
We have a track record of serving truly diverse clients, including:
- Corporates: From helping the C-suite refine strategy to powering innovation in marketing and R&D, our corporate use cases are endless. ​
- Investment firms: We help financial analysts develop robust long-term strategies and get alpha signals before the rest. ​
- Professional services: We give consultants, legal, and accounting firms the critical insights to make faster, more informed decisions. ​
- Other sectors: From media to academia, we work with sectors as diverse as our data. ​
The trusted, actionable and future-proof insight you need to stay ahead
We have decades of experience in being the gold standard intelligence provider based on: ​
- Unique data: Proprietary datasets built from terabytes of data. Our unmatched intelligence gives you true strategic advantage.
- Expert analysis: Leverage collective expertise. Count on our extensive team of researchers, analysts, subject matter experts, and journalists, plus thousands of external thought-leaders.​
- Real intelligence over AI: Experience a level of analysis that leaves AI in the dust. Unlock the proprietary datasets unseen by AI and gain a decisive edge. ​
- Time-saving research solutions: Save hundreds of hours on research. Our comprehensive reports let you focus on delivering actionable insights - not searching for them. ​
- Unparalleled global coverage: Tap into insights from anywhere. Our extensive global coverage offers an unrivalled view of the market landscape.​
- One platform: Access all our unique data, expert analysis, and innovative solutions on one platform. ​
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Rifamycin Sodium Cr in Diverticulitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Rifamycin Sodium Cr in Diverticulitis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Rifamycin Sodium Cr in DiverticulitisDrug Details:Rifamycin sodium (Aemcolo, Relafalk) is an anti-infective...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Sirolimus in Chondrosarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Sirolimus in Chondrosarcoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Sirolimus in ChondrosarcomaDrug Details:Sirolimus (Rapamun, Rapamune, Rapalimus) is a macrolide lactams derivative drug belongs...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Sirolimus in Myxoid Liposarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Sirolimus in Myxoid Liposarcoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Sirolimus in Myxoid LiposarcomaDrug Details:Sirolimus (Rapamun, Rapamune, Rapalimus) is a macrolide lactams derivative...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Memantine Hydrochloride in Vascular Dementias
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Memantine Hydrochloride in Vascular Dementias report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Memantine Hydrochloride in Vascular DementiasDrug Details:Memantine Hydrochloride (Namenda / Ebixa / Axura...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Tesevatinib Tosylate in Metastatic Brain Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tesevatinib Tosylate in Metastatic Brain Tumor report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Tesevatinib Tosylate in Metastatic Brain TumorDrug Details: Tesevatinib tosylate (KD-019, XL647)...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Everolimus in Myelodysplastic Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Everolimus in Myelodysplastic Syndrome report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Everolimus in Myelodysplastic Syndrome Drug Details: Everolimus (Afinitor, Votubia, RAD001) is...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Everolimus in Ependymoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Everolimus in Ependymoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Everolimus in Ependymoma Drug Details: Everolimus (Afinitor, Votubia, RAD001) is an ester...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Ramucirumab in Urethral Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ramucirumab in Urethral Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ramucirumab in Urethral Cancer Drug Details: Ramucirumab (Cyramza) is an antineoplastic agent....
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Cabozantinib s-malate in Meningioma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cabozantinib s-malate in Meningioma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cabozantinib s-malate in Meningioma Drug Details: Cabozantinib s-malate (XL184, BMS907351, Cometriq) is...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Cabozantinib s-malate in Rhabdomyosarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cabozantinib s-malate in Rhabdomyosarcoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cabozantinib s-malate in Rhabdomyosarcoma Drug Details: Cabozantinib s-malate (XL184, BMS907351, Cometriq) is...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.